Amphetamine analogs have differential effects on DRL 36-s schedule performance
Tóm tắt
Amphetamine and related compounds have previously been shown to differentially release dopamine (DA) and serotonin (5HT) in vivo and in vitro. The purpose of this report is directly to compare five amphetamine analogs on differential reinforcement of low rate 36-s (DRL 36-s) schedule performance, and to determine whether the reported increases in dopamine and/or serotonin release induced by these drugs can be related to observed behavioral differences. Amphetamine (AMPH) and methamphetamine (METH) induced large increases in response rate, methylene-dioxymethamphetamine (MDMA) and para-chloroamphetamine (PCA) caused small increases in response rate, while fenfluramine (FEN) had no effect on response rate. AMPH, METH, PCA and MDMA caused a dose-dependent decrease in reinforcement rate, and FEN had no effect on reinforcement rate. AMPH, METH, and PCA but not FEN, shifted the peak of the inter-response time (IRT) distribution toward shorter intervals, MDMA decreased peak location only at the highest dose. All five drugs caused a dose-dependent decrease in peak area, indicating a loss of schedule control on the DRL 36-s schedule. Consistent with in vitro and in vivo release studies, the differential results of these five drugs on DRL 36-s schedule performance suggest a predominant dopamine role for AMPH and METH, a predominant serotonin role for FEN, and different degrees of combined dopaminergic and serotonergic roles for MDMA and PCA in the mediation of the task.
Tài liệu tham khảo
Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1–8
Breese GR, Cooper, BR, Mueller, RA (1974) Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine. Br J Pharmacol 52:307–314
Broadbent J, Appel JB, Michael EK, Ricker JH (1992) Discriminative stimulus effects of the optical isomers of 3,4-methylene-dioxyamphetamine (MDA). Behav Pharmacol 3:443–454
Campbell JC, Seiden LS (1973) Performance influence on the development of tolerance to amphetamine. Pharmacol Biochem Behav 1[6]:703–708
Carter CJ, Pycock CJ (1978) Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour. Life Sci 23:953–960
Gold LH, Koob GF, Geyer MA (1988) Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine andN-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther 247:547–555
Hollister AS, Breese GR, Kuhn CM, Cooper BR, Schanberg SM (1976) An inhibitory role for brain serotonin-containing systems in the locomotor effects ofd-amphetamine. J Pharmacol Exp Ther 198:12–22
Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269–276
Kannengiesser M, Hunt PF, Raynaud J (1976) Comparative action of fenfluramine on the uptake and release of serotonin and dopamine. Eur J Pharmacol 35:35–43
Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260:78–89
Kuczenski R, Segal D (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051–2065
Li AA, Marek GJ, Vosmer G, Seiden LS (1989) Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacol Biochem Behav 33:641–648
Liang NY, Rutledge CO (1982) Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem Pharmacol 31[6]:983–992
Lyon M, Robbins TW (1975) The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. In: Essmand WB, Valzelli L (eds) Current developments in psychopharmacology. Spectrum, New York, pp 79–163
McKenna DJ, Guan XM, Shulgin AT (1991) 3,4-Methylene-dioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of3H-dopamine and3H-5-hydroxytryptamine. Pharmacol Biochem Behav 38:505–512
Neter J, Wasserman W (1974) Applied linear statistical models. Richard D. Irwin, Homewood, Ill.
Parsons LH, Justice JB (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res 606:195–199
Paulus MP, Geyer MA (1992) The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15–31
Richards JB, Seiden LS (1991) A quantitative inter-response-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. J Exp Anal Behav 56:173–192
Richards JB, Sabol KE, Seiden LS (1993a) DRL inter-response-time distributions: quantification by peak deviation analysis. J Exp Anal Behav 60:361–385
Richards JB, Sabol KE, Seiden LS (1993b) Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance. J Pharmacol Exp Ther 267:1256–1263
Richards JB, Sabol KE, Hand TH, Jolly DC, Marek GJ, Seiden LS (1994) Buspirone, gepirone, ipsapirone, and zalospirone have unique effects on the differential-reinforcement-of-low-rate 72-second schedule when compared to 5-HTP and diazepam. Psychopharmacology 114:39–46
Robbins TW (1981) Behavioural determinants of drug action: rate-dependency revisited. In: Cooper SJ (ed) Theory in psychopharmacology. Academic Press, New York, pp 1–63
Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxy-methamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747–755
Schmidt CJ, Black CK, Taylor VL (1991)l-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetaminep-chloroamphetamine or methamphetamine to rats. Eur J Pharmacol 203:41–49
Schuster CR, Dockens WS, Woods JH (1966) Behavioral variables affecting the development of amphetamine tolerance. Psychopharmacologia 9:170–182
Segal DS (1976) Differential effects of para-chlorophenylalanine on amphetamine-induced locomotion and stereotypy. Brain Res 116:267–276
Sharp T, Zetterstrom T, Christmanson L, Ungerstedt U (1986)p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo. Neurosci Lett 72:320–324
Trulson ME, Jacobs BL (1976) Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol 36:149–154
Warbritton JD, Stewart RM, Baldessarini RJ (1978) Decreased locomotor activity and attenuation of amphetamine hyperactivity with intraventricular infusion of serotonin in the rat. Brain Res 143:373–382